- Report
- June 2024
- 50 Pages
Global
From €2526EUR$2,650USD£2,153GBP
- Report
- January 2024
- 269 Pages
Global
From €6655EUR$7,225USD£5,481GBP
- Report
- December 2023
- 145 Pages
Global
From €5672EUR$5,950USD£4,835GBP
- Report
- May 2024
- 135 Pages
Global
From €6196EUR$6,499USD£5,281GBP
- Report
- February 2024
- 150 Pages
Global
From €4528EUR$4,750USD£3,860GBP
- Report
- January 2024
- 200 Pages
Global
From €3956EUR$4,150USD£3,372GBP
- Report
- April 2023
- 175 Pages
Global
From €5624EUR$5,899USD£4,793GBP
- Report
- February 2023
- 100 Pages
Global
From €2622EUR$2,750USD£2,235GBP
From €3337EUR$3,500USD£2,844GBP
- Report
- December 2022
- 75 Pages
Saudi Arabia
From €3337EUR$3,500USD£2,844GBP
- Report
- February 2024
- 75 Pages
Global
From €3500EUR$3,933USD£3,088GBP
- Report
- January 2024
- 113 Pages
Global
From €3500EUR$3,933USD£3,088GBP
- Report
- November 2021
- 220 Pages
Global
From €2288EUR$2,400USD£1,950GBP
- Report
- October 2023
- 306 Pages
Global
From €3403EUR$3,570USD£2,901GBP
Azithromycin is an antibiotic used to treat a wide range of bacterial infections. It is a macrolide-type antibiotic, which works by stopping the growth of bacteria. Azithromycin is commonly used to treat respiratory infections, skin infections, ear infections, and sexually transmitted diseases. It is also used to prevent certain bacterial infections in people with weakened immune systems. Azithromycin is available in both oral and intravenous forms, and is often prescribed in combination with other antibiotics.
Azithromycin is one of the most widely prescribed antibiotics in the world. It is generally well-tolerated and has a low risk of side effects. It is also relatively inexpensive, making it an attractive option for many patients.
The azithromycin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more